Log inSign up
Image
user avatar
Oscar Arrieta
@ogarrieta
Head of the Thoracic Oncology Unit @utoracica and the Personalized Medicine Lab, Instituto Nacional de Cancerología 🇲🇽 @incanmx, Medicine Professor @UNAM_MX
Mexico City
researchgate.net/profile/Oscar_…
Joined June 2010
1,186
Following
3,907
Followers
  • Pinned
    user avatar
    Oscar Arrieta
    @ogarrieta
    Jul 5, 2023
    Replying to @LungPolicy
    The National Institute of Cancerology of Mexico @incanMX is present on the lung cancer screening map with DETECTO program @detectoincan @LungPolicy We want to expand screening to several cities in Mexico and LATAM @SMNYCT lungcancerpolicynetwork.com/interactive-ma…
    Image
    20K
  • user avatar
    Oscar Arrieta
    @ogarrieta
    Feb 13, 2025
    Felicitamos a los nuevos oncólogos médicos del ⁦@incanMX⁩, agradecemos su dedicación y esfuerzo por el bienestar de nuestros pacientes ⁦@anelcabrera⁩ ⁦@docenciaincan⁩
    Image
    74K
  • user avatar
    Oscar Arrieta
    @ogarrieta
    Jul 7, 2020
    Tratamiento del cáncer. Nuestro Libro fue recientemente publicado por manual moderno. Gracias a todos los autores por su aportación @incanMX tienda.manualmoderno.com/tratamiento-de…
    Image
  • user avatar
    Oscar Arrieta
    @ogarrieta
    Sep 1, 2020
    Tocilizumab decreased the risk of intubation or death in COVID-19 in a Spanish RETROSPECTIVE study (0.32, p <0.001) in patients with elevated ferritin, dd or IL-6, Suggesting that the selection of patient in future clinical studies it should be based on the state of inflammation
    Image
  • user avatar
    Oscar Arrieta
    @ogarrieta
    Jan 31, 2025
    El trabajo de tesis de alta especialidad de urología oncologica del @incanMX “La radiómica y su correlación histológica en pacientes con tumor germinal no seminomatoso operados de linfadenectomía retroperitoneal posterior a recibir quimioterapia” del Dr Alejandro Fuentes obtuvo
    Image
    00:00
    Image
    Image
    16K
  • user avatar
    Oscar Arrieta
    @ogarrieta
    Jan 12, 2024
    Our randomized, double-blind, placebo-controlled clinical trial recently published in @JAMAOnc shows that mirtazapine compared to placebo improves energy and oral intake including proteins, carbohydrates and fats in NSCLC patients. The mirtazapine group decreased sarcopenia
    Image
    Image
    22K
  • user avatar
    Oscar Arrieta
    @ogarrieta
    Feb 26, 2021
    Prophylactic Cranial Irradiation has not been evaluated in advanced NSCLC patients at high risk for brain metastases. We conducted a randomized study where we showed that PCI was associated with a reduction to develop BM (0.12 [0.035-0.42], particularly in mEGFR and ALK @incanMX
    Image
    Image
  • user avatar
    Oscar Arrieta
    @ogarrieta
    May 5, 2021
    Approximately 65% of lung adenocarcinomas elevate the carcinomebrionic antigen. The reduction of more than 20% of CEA levels with chemotherapy or EGFR TKI is strongly associated with an improvement in survival. This is shown by our study recently published in clinical lung cancer
    Image
  • user avatar
    Oscar Arrieta
    @ogarrieta
    Sep 29, 2023
    Our study demonstrated that increased perilesional edema (PE) from brain metastases (BM) from NSCLC is a negative predictor of response to radiation therapy, short intracranial-PFS, and even worse OS. The PE should be evaluated to be integrated into the BM prognostic scales.
    Image
    13K
  • user avatar
    Oscar Arrieta
    @ogarrieta
    Nov 26, 2020
    Clausura del año académico @ANacionalMed. La doctora Patrícia Volkow es reconocida con la mejor trayectoria científica a las mujeres en medicina, miembro del @incanMX @dvilarc
    Image
    Image
  • user avatar
    Oscar Arrieta
    @ogarrieta
    Oct 4, 2023
    Hoy iniciamos el curso "Implementación de registros de cáncer de base poblacional" avalado por la @UNAMmx y la @FacMedicinaUNAM, un paso más en el fortalecimiento del registro en nuestro país y un trabajo de colaboración entre @Tu_IMSS @SSalud_mx @incanMX con el liderazgo de
    Image
    9.6K
  • user avatar
    Oscar Arrieta
    @ogarrieta
    Aug 26, 2020
    Due to the COVID-19 pandemic, a significant delay in the diagnosis and treatment of cancer has been observed, this will generate a reduction in the expectation of survival. Shown here reduction in net 10-year survival incurred by a 3-month delay for the 20 most common tumors.
    Image
  • user avatar
    Oscar Arrieta
    @ogarrieta
    Jul 4, 2021
    En el @incan 99.2% de todos los casos de cáncer de pulmón son diagnosticados en etapas avanzadas (III y IV) con menor posibilidad de curación y un costo de atención 10 veces superior que las etapas tempranas. Por eso iniciamos el programa de tamizaje @detectoincan en el Instituto
    Image
  • user avatar
    Oscar Arrieta
    @ogarrieta
    Jul 10, 2024
    Most lung cancer screening programs primarily target subjects with a history of smoking as the leading risk factor. Our recently published review discusses risk prediction models to optimize screening in non-smokers to accurately identify individuals who should be included in
    Image
    12K